NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
Press Release
Read More
NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Press Release
Read More
Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy
Literature
Read More
NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024
Press Release
Read More
Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month
Press Release
Read More
Comparative analysis of actionable gene reporting in targeted panels versus comprehensive NGS testing for solid tumor samples
Literature
Read More